4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001209191-18-021936
10% owner bought 6,571,164 shares at an average $1.92 ($12,587,753)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| New Enterprise Associates 14, L.P. 10% owner | 2018-03-26 | Purchase | +571,164 | $1.90 | $1,087,553 | 73,978,672 | D |
| New Enterprise Associates 14, L.P. 10% owner | 2018-03-27 | Purchase | +6,000,000 | $1.92 | $11,500,200 | 79,978,672 | D |
| Open-market purchases · 6,571,164 sh · avg $1.92 · $12,587,753 | |||||||
Loading xslF345X03/doc4.xml…